[
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Vosoritide (Expanded Indications)",
    "disease_indication": [
      "Other Growth Disorders (beyond Achondroplasia)"
    ],
    "development_phase": "Phase III",
    "moa": "C-type Natriuretic Peptide (CNP) analog",
    "route_of_admin": "Subcutaneous",
    "status": "Active",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFc9l2QX5i5jAGIBR8suc4mNYBbSWE4dTCk8TtRohkKJ8Hc4FIR9i0bSvNcSfPvD9VaFgv-nozzCk0NQw85vQuB1rrIMhelDob5tcjLRjKh16OjU5TujuOUnNZvND4vvZgpH_NMaBielI6cSiSQuIGB6lrhfgXEzanVzI97udmtIGyptSy_Ys7yyZSlxaqirjXj6vjvMaKu9rlNOC8j2TO8RrpICvavPh7T"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Palynziq (pegvaliase-pqpz) (Expanded Indications)",
    "disease_indication": [
      "Phenylketonuria (PKU) in adolescents aged 12-17"
    ],
    "development_phase": "Approved",
    "moa": "Enzyme substitute therapy",
    "route_of_admin": "Null",
    "status": "Active",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFNb7I0JFBTpEpyZ8VHO95X0DHyVAMRb9W-tGEkLKx7oNNsdvdCKZ9rmkHqm2cDH1sw-KJbPMW5t8wS2bzZCprr7hoK9xzeO5fln4KbBdOzlGWv-YQ="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 333",
    "disease_indication": [
      "Multiple Growth Disorders"
    ],
    "development_phase": "Phase I",
    "moa": "Null",
    "route_of_admin": "Null",
    "status": "Active (Accelerated)",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbFNvu-a8GQXaRn55hJ3dELy19t-UqKN4_M_qvzthUSFKO7olWlrIlJ2a3qdStTiP-v56rMGuxuK6EH-rAKee6iRzVj_mHVC4sRx3EoPHbkFz2cGYcHqFVcVCREWVLuzigDxRGuw5DrnehEPT-ccbQK1utrTf7ejtV2JUp0vMOv7vF0az4dFcY8hTFKN1gxwT0yTo8OChTwQ_P"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 349",
    "disease_indication": [
      "Alpha-1 Antitrypsin Deficiency (AATD)-associated Liver Disease"
    ],
    "development_phase": "Phase I",
    "moa": "Null",
    "route_of_admin": "Null",
    "status": "Active (Accelerated)",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbFNvu-a8GQXaRn55hJ3dELy19t-UqKN4_M_qvzthUSFKO7olWlrIlJ2a3qdStTiP-v56rMGuxuK6EH-rAKee6iRzVj_mHVC4sRx3EoPHbkFz2cGYcHqFVcVCREWVLuzigDxRGuw5DrnehEPT-ccbQK1utrTf7ejtV2JUp0vMOv7vF0az4dFcY8hTFKN1gxwT0yTo8OChTwQ_P"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 351",
    "disease_indication": [
      "Duchenne Muscular Dystrophy (DMD)"
    ],
    "development_phase": "Phase I",
    "moa": "Null",
    "route_of_admin": "Null",
    "status": "Active (Accelerated)",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbFNvu-a8GQXaRn55hJ3dELy19t-UqKN4_M_qvzthUSFKO7olWlrIlJ2a3qdStTiP-v56rMGuxuK6EH-rAKee6iRzVj_mHVC4sRx3EoPHbkFz2cGYcHqFVcVCREWVLuzigDxRGuw5DrnehEPT-ccbQK1utrTf7ejtV2JUp0vMOv7vF0az4dFcY8hTFKN1gxwT0yTo8OChTwQ_P"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Unnamed Enzyme Replacement Therapy",
    "disease_indication": [
      "ENPP1 Deficiency"
    ],
    "development_phase": "Phase III",
    "moa": "Enzyme Replacement Therapy",
    "route_of_admin": "Null",
    "status": "Active",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHg5o-cCDhGoRDvPkP2tbhybpkgff1j0oRd7-CgX7Ub0KzB-n2AZgTdKfbUTJ_D7zGEtgD_Wp3O_Gabck_mLHjlRs1BaMzZ92hWjKW8nC5LtBHFLzJ7sBKnRWSmLWfeYXsuAU114UFMOAxbfYvANv0Flj06RA5k77S6OInsp8QiuAjlYJopeT9biLDKbzcEzSdM1pk12Jsl5K6w1XOaMo4srg8zsaV-hAWN6rk="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 355",
    "disease_indication": [
      "Long-QT Syndrome Types 2 and 3"
    ],
    "development_phase": "Preclinical",
    "moa": "Monoclonal Antibody",
    "route_of_admin": "Null",
    "status": "Discontinued",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbFNvu-a8GQXaRn55hJ3dELy19t-UqKN4_M_qvzthUSFKO7olWlrIlJ2a3qdStTiP-v56rMGuxuK6EH-rAKee6iRzVj_mHVC4sRx3EoPHbkFz2cGYcHqFVcVCREWVLuzigDxRGuw5DrnehEPT-ccbQK1utrTf7ejtV2JUp0vMOv7vF0az4dFcY8hTFKN1gxwT0yTo8OChTwQ_P"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 365",
    "disease_indication": [
      "PKP2 Arrhythmogenic Cardiomyopathy"
    ],
    "development_phase": "Preclinical",
    "moa": "Null",
    "route_of_admin": "Null",
    "status": "Discontinued",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbFNvu-a8GQXaRn55hJ3dELy19t-UqKN4_M_qvzthUSFKO7olWlrIlJ2a3qdStTiP-v56rMGuxuK6EH-rAKee6iRzVj_mHVC4sRx3EoPHbkFz2cGYcHqFVcVCREWVLuzigDxRGuw5DrnehEPT-ccbQK1utrTf7ejtV2JUp0vMOv7vF0az4dFcY8hTFKN1gxwT0yTo8OChTwQ_P"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 331",
    "disease_indication": [
      "Hereditary Angioedema"
    ],
    "development_phase": "Phase I",
    "moa": "Gene Therapy",
    "route_of_admin": "Null",
    "status": "Discontinued",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbFNvu-a8GQXaRn55hJ3dELy19t-UqKN4_M_qvzthUSFKO7olWlrIlJ2a3qdStTiP-v56rMGuxuK6EH-rAKee6iRzVj_mHVC4sRx3EoPHbkFz2cGYcHqFVcVCREWVLuzigDxRGuw5DrnehEPT-ccbQK1utrTf7ejtV2JUp0vMOv7vF0az4dFcY8hTFKN1gxwT0yTo8OChTwQ_P"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 255",
    "disease_indication": [
      "Metabolic Dysfunction-Associated Steatohepatitis (MASH)"
    ],
    "development_phase": "Phase I",
    "moa": "Null",
    "route_of_admin": "Oral",
    "status": "Discontinued",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHbFNvu-a8GQXaRn55hJ3dELy19t-UqKN4_M_qvzthUSFKO7olWlrIlJ2a3qdStTiP-v56rMGuxuK6EH-rAKee6iRzVj_mHVC4sRx3EoPHbkFz2cGYcHqFVcVCREWVLuzigDxRGuw5DrnehEPT-ccbQK1utrTf7ejtV2JUp0vMOv7vF0az4dFcY8hTFKN1gxwT0yTo8OChTwQ_P"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 390",
    "disease_indication": [
      "Phenylketonuria (PKU)"
    ],
    "development_phase": "Preclinical",
    "moa": "Enzyme Substitute Therapy (modified PEGylation)",
    "route_of_admin": "Null",
    "status": "Discontinued",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHg5o-cCDhGoRDvPkP2tbhybpkgff1j0oRd7-CgX7Ub0KzB-n2AZgTdKfbUTJ_D7zGEtgD_Wp3O_Gabck_mLHjlRs1BaMzZ92hWjKW8nC5LtBHFLzJ7sBKnRWSmLWfeYXsuAU114UFMOAxbfYvANv0Flj06RA5k77S6OInsp8QiuAjlYJopeT9biLDKbzcEzSdM1pk12Jsl5K6w1XOaMo4srg8zsaV-hAWN6rk="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "BMN 290",
    "disease_indication": [
      "Friedreich's Ataxia"
    ],
    "development_phase": "Preclinical",
    "moa": "Selective Chromatin Modulation Therapy",
    "route_of_admin": "Null",
    "status": "Inactive/Unclear (Last known: IND planned 2018, no recent updates)",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGuH8ztyLaVm0T-rhcrw57fzyv57qZAXUkLWvRThvEiy6nicNK-dTDiJkOlw0FPPw_02JSvlVQeqaLAlQCL81qF6jXnffV0WwYAnFuMeri-YWlsKgznrE0ZYbhXWiSaClxkxMPGL_Gpil-cXTwY4efiA_flrgiuy8yMkICHtGENwuPh_sYWrYU-mgSy7dBoneZ4n-oINS19ZhJ9OULESQ-_vRbbnbmA5IhhbfkE0fCjHKUCCJCfCwOCU7SNiFi2RuzeJvmbcvBfmVDfPhRAp71ERYM4tPC-DLc="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Voxzogo (Vosoritide)",
    "disease_indication": [
      "Achondroplasia"
    ],
    "development_phase": "Approved",
    "moa": "C-type Natriuretic Peptide (CNP) analog",
    "route_of_admin": "Subcutaneous",
    "status": "Approved",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFc9l2QX5i5jAGIBR8suc4mNYBbSWE4dTCk8TtRohkKJ8Hc4FIR9i0bSvNcSfPvD9VaFgv-nozzCk0NQw85vQuB1rrIMhelDob5tcjLRjKh16OjU5TujuOUnNZvND4vvZgpH_NMaBielI6cSiSQuIGB6lrhfgXEzanVzI97udmtIGyptSy_Ys7yyZSlxaqirjXj6vjvMaKu9rlNOC8j2TO8RrpICvavPh7T"
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Roctavian (valoctocogene roxaparvovec)",
    "disease_indication": [
      "Severe Hemophilia A"
    ],
    "development_phase": "Approved",
    "moa": "Gene Therapy",
    "route_of_admin": "Intravenous",
    "status": "Approved",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFOwuY3UiITtGY4B4elTl0mR4xemHEVmWnwKHazyjJ7M6YKn2g9rxbUiMiAZsXYvpaRuFZNYWwDcOPLkzvjSq8SUtf-g6CopSRM1ckvtocr6r-RHV4YC7PDtJ4lMQN86LouhKWdNK28eR4ub08eJ5yv5Nf6PnYiKIkCVajCBE29bojsL4qws9FixmI3fNhMmEc8IezyF_5YaCPAi9B7eA2cZR042cQLaOC_T4ZeuA5EIF8="
    ]
  },
  {
    "sponsor_name": "BioMarin Pharmaceutical Inc.",
    "candidate_name": "Palynziq (pegvaliase-pqpz)",
    "disease_indication": [
      "Phenylketonuria (PKU)"
    ],
    "development_phase": "Approved",
    "moa": "Enzyme Substitute Therapy",
    "route_of_admin": "Null",
    "status": "Approved",
    "source_url": [
      "https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQFNb7I0JFBTpEpyZ8VHO95X0DHyVAMRb9W-tGEkLKx7oNNsdvdCKZ9rmkHqm2cDH1sw-KJbPMW5t8wS2bzZCprr7hoK9xzeO5fln4KbBdOzlGWv-YQ="
    ]
  }
]